Concerted Regulation of Inhibitory Activity of
1-Antitrypsin by the Native Strain Distributed
throughout the Molecule*
Eun Joo
Seo,
Cheolju
Lee
, and
Myeong-Hee
Yu§
From the National Creative Research Initiatives, Protein Strain
Research Center, Korea Institute of Science and Technology, P. O. Box
131, Cheongryang, Seoul 130-650, Korea
Received for publication, October 25, 2001, and in revised form, February 5, 2002
 |
ABSTRACT |
The native forms of common globular proteins are
in their most stable state but the native forms of plasma serpins
(serine protease inhibitors) show high energy state interactions. The high energy state strain of
1-antitrypsin, a
prototype serpin, is distributed throughout the whole molecule, but the
strain that regulates the function directly appears to be localized in
the region where the reactive site loop is inserted during complex formation with a target protease. To examine the functional role of the
strain at other regions of
1-antitrypsin, we increased the stability of the molecule greatly via combining various stabilizing single amino acid substitutions that did not affect the activity individually. The results showed that a substantial increase of stability, over 13 kcal mol
1, affected the inhibitory
activity with a correlation of 11% activity loss per kcal
mol
1. Addition of an activity affecting single residue
substitution in the loop insertion region to these very stable
substitutions caused a further activity decrease. The results suggest
that the native strain of
1-antitrypsin distributed
throughout the molecule regulates the inhibitory function in a
concerted manner.
 |
INTRODUCTION |
The native forms of common globular proteins are in their most
stable state and protein folding is a spontaneous process (1). However,
the native forms of some proteins are not in their most stable state:
typical examples are the strained native structure of plasma
serpins1 (serine protease
inhibitors) (2), the spring-loaded structure of the fusion protein of
some viruses (3, 4), and heat shock transcription factors (5). The high
energy state of the native structure of serpins is considered to be
crucial to their physiological functions, such as plasma protease
inhibition (1, 6), hormone delivery (7), Alzheimer filament assembly
(8, 9), and extracellular matrix remodeling (10). The inhibition
process of serpins can be described as a suicide substrate mechanism
(11, 12), in which serpins, upon binding with proteases, partition between cleaved serpins (substrate pathway) and stable serpin-enzyme complexes (inhibitory pathway) as described in Scheme 1.
In this scheme, I denotes the serpin; E,
protease; EI, noncovalent Michaelis complex;
E-I, a proposed intermediate prior to partitioning;
E-I*, stable enzyme-inhibitor complex; and I*,
cleaved serpin. The stoichiometry of inhibition (SI, the number of
moles of inhibitors required to completely inhibit 1 mol of a target protease) is given by 1 + ksubstrate/kinhibition,
in which ksubstrate and
kinhibition are the rate constants for the
substrate and inhibitory pathways, respectively. The crystal structure
of a serpin-protease complex revealed that the reactive site loop of
the serpin is cleaved and inserted into the major
-sheet, sheet A,
in the complex, whereas the target protease is attached to the cleaved
loop of the serpin as an acyl intermediate (13). The conformational conversion during complex formation accompanies the distortion of the
protease active site (13), which prevents catalytic deacylation and
results in trapping the stabilized complex. Flexibility of the native
serpin structure is required for conformational conversion, and the
high energy state of the native conformation appears to be a driving
force for this conversion.
To understand the structural basis and mechanistic consequences of the
high energy state of native serpins, we have characterized stabilizing
amino acid substitutions of human
1-antitrypsin
(
1AT), a prototype serpin (14-18). In the crystal
structure of the native
1AT (19, 20), unfavorable
interactions such as side chain overpacking, buried polar groups,
internal cavities, and surface hydrophobic pockets occur (16, 17).
These unfavorable interactions can be replaced by stabilizing
substitutions (21, 22). We screened thermostable mutations over the
entire
1AT molecule and found stabilizing mutations that
influence the flexibility of the native state distributed throughout
the molecule (17). If the increase in the stability of the native state
of
1AT is manifested in the formation of the inhibitory
complex, there should be a correlation between that increase in
stability and the loss of inhibitory activity. Interestingly, however,
only the stabilizing substitutions in the loop insertion region, such
as Lys335 (23) and Gly117 (18) of sheet A,
decreased the inhibitory activity, and the stabilizing mutations at
most other sites of
1AT did not cause the activity loss
(17). It was shown recently that cavity filling substitutions designed
at several sites of
1AT increased the stability of the
molecule, but activity affecting mutations among them were localized in
the region that appears to be mobilized during the loop insertion (22).
Thus, the high energy state in the loop insertion region appeared to be
a nature's design for functional regulation but such a role of the
strain at most other sites was not obvious. In the present study, we
addressed this point by examining very stable mutations that were made
through combining various single residue substitutions that did not
affect the inhibitory activity individually. Characterization of the stable mutations suggests that the strain of
1AT
scattered over the molecule does regulate the inhibitory activity.
 |
MATERIALS AND METHODS |
Chemicals--
Ultrapure guanidine hydrochloride was purchased
from ICN Biochemicals, Inc. (Aurora, IL). Porcine pancreatic elastase
(PPE), human leukocyte elastase (HLE),
N-succinyl-(Ala)3-p-nitroanilide, and
N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide
were purchased from Sigma. All other chemicals were reagent grade.
Recombinant
1AT Proteins--
The plasmid for
1AT expression in Escherichia coli and the
purification of recombinant proteins were described previously (14).
Protein concentration was determined in 7 M guanidine hydrochloride, calculated from tyrosine and tryptophan content of the
1AT protein (24). Amino acid substitutions at specific sites were generated by oligonucleotide-directed mutagenesis and confirmed by DNA sequencing.
1AT cleaved at the reactive
site loop was prepared by incubating with PPE at a molar ratio of 1:0.4 (
1AT:protease) at 37 °C for 1 h in a buffer
containing 50 mM Tris-HCl, 50 mM NaCl, pH 8.0. Phenylmethylsulfonyl fluoride was added at a final concentration of 1 mM to stop the reaction. Uncleaved molecules were removed
by precipitating them at 70 °C for 15 min. The cleaved form was
purified by ion exchange chromatography on MonoQ column in 10 mM phosphate, 1 mM
-mercaptoethanol, 1 mM EDTA, pH 6.5. Cleavage of
1AT was
confirmed by 10% SDS-polyacrylamide gel electrophoresis and Coomassie
Brilliant Blue staining.
Equilibrium Unfolding--
Equilibrium unfolding was carried out
as a function of guanidine hydrochloride in 10 mM
phosphate, 50 mM NaCl, and 1 mM EDTA, pH 6.5. The transition was monitored at 25 °C by change in fluorescence intensity (
ex = 280 nm,
em = 360 nm) on
RF-5000 spectrofluorometer (Shimazu) or circular dichroism (CD) signal
at 222 nm on Jasco-720 spectropolarimeter in 1-cm path length cell. The
native protein was pre-equilibrated in the buffer containing various
concentrations of guanidine hydrochloride at 25 °C for 4 h. The
concentration of protein was 10 and 20 µg/ml for spectrofluorometry
and CD spectroscopy, respectively. Equilibrium unfolding monitored by
fluorescence change was fitted to a two-state model or three-state
model and changes in the unfolding stability was determined according
to Pace and co-workers (25). Briefly, it was calculated with the fitted
thermodynamic parameters and the equation, 
G = <m> ×
Cm, where
Cm is the difference between the values of
Cm, equilibrium transition midpoint, for the wild
type and mutant protein, and <m> is the average of the
"m-value," a measure of the dependence of the free
energy of unfolding (
G) on denaturant concentration. The
<m> value used in the present study was 7.6 kcal
mol
1 M
1.
Determination of the Inhibitory Activity--
The SI was
determined as described (11). Various amounts of purified recombinant
1AT proteins were incubated with 100 nM PPE
or HLE at designated molar ratios of
1AT to protease in
50 µl of assay buffer (30 mM phosphate, 160 mM NaCl, 0.1% PEG 8000, and 0.1% Triton X-100, pH 7.4).
After incubation with the protease at 37 °C for 10 min, the reaction
mixture was diluted 10-fold with the assay buffer and residual enzyme
activity was determined. The active concentration of PPE was determined
by measuring the initial rates of hydrolysis of 1 mM
N-succinyl-(Ala)3-p-nitroanilide (26). The active concentration of HLE was determined as described previously (27) with trypsin-titrated human plasma
1AT
and a substrate,
N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide. The activity inhibition was extrapolated to yield the minimum molar
ratio of
1AT to the protease giving 100% inhibition.
The association rate constant for the interaction of recombinant
1AT with PPE was measured under second order conditions
(28) in a reaction mixture containing equimolar concentrations (8 nM) of the protease and the inhibitor.
 |
RESULTS |
Conformational Properties of Stable
1AT
Variants--
Stable
1AT variants were constructed by
combining various single residue substitutions that increased
conformational stability without diminishing the inhibitory activity
(Fig. 1, colored cyan). Each
component substitutions of
1AT are located at various
secondary structures (helix A, helix B, helix C, helix H, helix F, and
the following loop, helix I and the following loop, strand 3 of
-sheet A, strands 2-6 of
-sheet B, and strands 1 and 2 of
-sheet C). Fig. 2A shows
the unfolding transition of several
1AT variants in the
presence of guanidine hydrochloride, which was monitored by the change
in intrinsic fluorescence intensity. By combining various stabilizing
substitutions of
1AT, the midpoint of unfolding transition (Cm) could be increased up to 3.29 from
0.65 M, the wild type value. The stabilizing effects of
various combinations are summarized in Table
I. The stability of M16
1AT molecule that was cleaved in the reactive site loop
was comparable to that of the cleaved wild type (Fig. 2A,
filled symbols, Cm of 6.24 versus 5.91 M). The stability of other cleaved
mutant
1AT was also comparable. When the unfolding
transition was monitored by CD spectrometry, the wild type and M7
1AT showed biphasic transitions (Fig. 2B), in
which the transition at the lower denaturant concentration appeared to
coincide with the transition monitored by fluorescence intensity (Fig.
2B, dotted lines). The unfolding transition of
M13 and M16 monitored by CD showed single transitions with the
mid-point of 2.66 and 3.29 M, respectively (Fig.
2B), which are superimposable with the unfolding transitions
monitored by fluorescence (dotted lines).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 1.
A stereo diagram of
1AT showing individual amino acid
substitutions in combinatorial mutations. The atomic
coordinates for the crystal structure of native 1AT were
taken from the structure (PDB code: 1HP7) that was reported recently
(20). The substitution sites are depicted by beads. The site
of the activity affecting substitution, K335V, is colored
red. The reactive site loop is represented in
green, and the region mobilized upon insertion of the
reactive site loop (s3A, s5A, hF, and
the following loop) is represented in yellow. The figures
were prepared with MOLSCRIPT (37).
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Guanidine hydrochloride-induced unfolding
transition of the variant 1AT
carrying combinatorial mutations. A, unfolding was
monitored by the increase in fluorescence emission intensity at 360 nm
( ex = 280 nm). Samples (10 µg/ml) were incubated in
guanidine hydrochloride solution of 10 mM potassium
phosphate, 50 mM NaCl, 1 mM EDTA, 1 mM -mercaptoethanol, pH 6.5, at 25 °C for 4 h.
The data were fitted to a two-state unfolding model. , native
wild-type; , native M7; , native M13; , native M16; ,
cleaved wild-type; , cleaved M16. B, unfolding of
the native form was measured by the loss of CD ellipticity at 222 nm.
The protein concentration was 20 µg/ml. , wild type; , M7; ,
M13; , M16. The data of the wild type and M7 were fitted to a
three-state unfolding model, and those of M13 and M16 were fitted to a
two-state unfolding model. The dotted lines exhibit the
fitted two-state unfolding monitored by fluorescence intensity.
|
|
Inhibitory Function of Stable
1AT Variants--
To
investigate the effect of the stabilizing mutations on the inhibitory
activity of
1AT, the SI value of the variants
1AT toward HLE was measured. Fig.
3 shows that M13, M14b, and M16, but not
M7, increased the SI, and the degree of increase correlated with the
stability increase. The SI values of other variants
1AT are summarized in Table I. Table I also shows the mutational effect on
the inhibitory activity that was obtained from the SI values of the
wild type and the variant
1AT (relative activity). When
the SI values toward PPE were measured for several variant forms of
1AT, similar degrees of activity decrease were observed (data not shown). Table I also shows the ratios of partitioning between the substrate and inhibitory pathways
(ksubstrate over kinhibition) for each variant
1AT, which were obtained from the SI values (SI-1). When
the wild-type
1AT interacts with HLE, the partitioning
ratio is close to 0 because most of
1AT molecules form
the inhibitory complex. The stable mutation, M16, increased this ratio
up to 10, which indicates that less than 10% of the mutant molecules
formed the inhibitory complex and the rest were cleaved by HLE. The
association rate constant (ka) of the variants
1AT with PPE did not differ significantly from the wild
type value, 5.5 × 105 M
1
s
1 (data not shown). The association rate with HLE was
over 107 M
1 s
1 and
could not be determined precisely.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibitory activity of variant
1AT carrying combinatorial
mutations. The SI values of representative 1AT
variants against HLE were determined. , wild-type; , M7; ,
M13; , M14b; , M16. HLE (100 nM) was incubated with
various 1AT concentrations at designated molar ratios
([inhibitor])/[HLE]) indicated at the abscissa. The
lowest value of [inhibitor]/[HLE] giving 100% inhibition is the
estimated stoichiometry of inhibition.
|
|
Combination of the Multiple Stabilizing Substitutions with Activity
Affecting Single Residue Substitution--
Some of the previously
identified single residue substitutions caused activity decrease
although they increased the stability much less than M7 did. To examine
if the stable multiple substitutions constructed in the present study
affect the inhibitory activity in a similar way to that of the
previously identified activity affecting single residue substitutions,
K335V (Fig. 1, colored red) was combined with M5b, M7, and
M14a. Table II shows that the
combinations increased the stability as much as expected from the sum
of individual effects, and decreased the inhibitory activity more than
K335V.
 |
DISCUSSION |
We examined the combinatorial effect of the stabilizing
substitutions of
1AT that did not affect the activity
individually. Loss of inhibitory activity was observed with the current
set of the stabilizing mutations only when the stability increase was
substantial (Table I). In Fig. 4,
correlation between the stability increase of
1AT
and the decrease in the inhibition toward HLE was examined
(filled circles). Any significant decrease in activity was
not observed with the stability increase up to 13 kcal
mol
1, but the activity leveled off as the stability
increased further with a correlation of about 11% activity loss per
kcal mol
1. This degree of activity reduction toward HLE
was approximately similar to that toward PPE (data not shown). These
results clearly showed that a substantial stability increase by the
multiple substitutions could also affect the inhibitory function of
1AT, although each component substitution has inert
effect on the activity. The results suggest that high energy states of
1AT distributed throughout the molecule regulate
inhibitory function in a collective manner. Some single residue
substitutions in the loop insertion region, such as those at
Gly117 or Lys335 site, increased the stability
up to 6 kcal mol
1 with a concomitant decrease in the
inhibitory activity (16-18, 22). Gly117 and
Lys335 sites lie beneath helix F and the following loop
that cover
-sheet A at the bottom half in the loop insertion region
(Fig. 1), and flexibility in this region appears to be critical for the
loop insertion during the complex formation. Since simultaneous
stabilization at many other sites throughout the molecule is as
detrimental as the stabilization in the loop insertion region (Table
I), flexibility throughout the
1AT molecule may also be
critical for the complex formation.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
Correlation between stability and inhibitory
activity of 1AT. The values
of relative activity toward HLE are plotted as a function of
 G. , multiple combination mutations in Table I;
, K335V, K335 + M5b, K335V + M7, K335V + M14a in Table II in the
order of increasing stability. The dotted line represents
the best fit of the stability activity correlation among the activity
affecting combinatorial mutations.
|
|
Regulation of Inhibitory Activity by the Conformational Properties
of
1AT--
Various studies suggested that rapid loop
insertion in a serpin (12, 29-32) and active site distortion of the
protease (13, 33) confer inhibitory activity on the serpins.
Experimental data showed a direct correlation between retardation of
the loop insertion and the activity decrease (15, 34). The stability increase in the current set of mutant proteins may also influence the
complex formation by retarding the loop insertion. Why then is the
activity affected only when the stability increase is over 13 kcal
mol
1? Unfolding of the wild type
1AT is
biphasic, as probed by CD signal, although the change in fluorescence
intensity monitors only the first transition (Fig. 2). Very stable
variants that decreased the inhibitory activity such as M13 and M16
showed a single superimposable unfolding transition, whereas M7, which did not affect the activity, showed biphasic transition (Fig. 2B). Biphasic transition of equilibrium unfolding indicates
that the molecule is made of two folding domains. The intrinsic
fluorescence change monitors the environmental change near
Trp194 (35), the unique buried tryptophan residue at the
top of strand 3 of sheet A. It is very likely that equilibrium
fluorescence change reflects initial opening of sheet A, and unfolding
of
1AT can be considered as opening of sheet A followed
by further unfolding of the remaining secondary structures. For those
mutations that show a single transition, opening of sheet A appear to
be coupled with complete unfolding. It may be that such conformation
property of
1AT as domain folding is important for
proper complex formation with a target protease. There is another
possibility that the energy difference between the strained native
state and a more stable state in the complex becomes too small to trap
the protease-inhibitor complex as an acyl-enzyme inhibitor. It was
suggested that the energy difference is utilized for trapping the
protease-inhibitor complex (32, 36), presumably by distorting the
protease active site (13). If the difference becomes too small, the
proposed distortion and trapping may become inefficient. Further
studies will elucidate detailed mechanisms how the stability of a
serpin molecule regulates its inhibitory activity.
Concerted Regulation of the Inhibitory Function by the
Native Strain--
We examined how the stable multiple substitutions
constructed in the current study might influence the activity affecting single residue substitutions. The activity of K335V decreased further
down when a multiple substitution, such as M5, M7, or M14, was combined
(Table II; Fig. 4, open symbols). The results suggest that
at least two distinct steps are involved in the regulation of the
complex formation. The first step appears to be the destabilization of
the interactions between helix F and sheet A, which is affected by the
activity affecting single residue substitutions in this region
(e.g. K335V) but not by such multiple stable substitutions as M5 or M7. The step is likely to be independent of the changes in
fluorescence property and secondary structure contents. However, the
activity affecting single residue substitutions also shift the
unfolding midpoints monitored by fluorescence and CD signals with a
good correlation with the activity decrease (16, 18). Therefore, the
step is likely to be prerequisite to opening of sheet A detected by
fluorescence and CD. The second step is opening of
-sheet A for the
insertion and locking of the reactive site loop. This step appears to
require flexibility of the whole molecule, because the inhibitory
activity is affected when the step is coupled with global stability as
with the very stable multiple substitutions. Whereas the interactions
at specific location are important in the first step, collective
molecular properties may be as important in the second step. Our
results clearly suggest that high energy states of
1AT
regulate concertedly various steps of the complex formation.
In summary, we probed the functional role of the native strain of
1AT that is distributed throughout the molecule.
Although stability of the wild type
1AT is optimized and
is designed in such a way that the activity is not sensitive to a minor
change in the stability, a substantial stability increase of
1AT affected the inhibitory activity of the molecule.
The opening of sheet A, a critical step for the loop insertion, appears
to be regulated by such conformational properties as domain folding and
global stability as well as local high-energy states in the loop
insertion region.
 |
FOOTNOTES |
*
This work was supported by a National Creative Research
Initiatives grant from the Korean Ministry of Science and Technology.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Korea Research Institute of Bioscience and
Biotechnology, P. O. Box 115 Yusong, Taejon 305-600, Korea.
§
To whom correspondence should be addressed. Tel.: 82-2-958-6911;
Fax: 82-2-958-6919; E-mail: mhyu@.kist.re.kr.
Published, JBC Papers in Press, February 7, 2002, DOI 10.1074/jbc.M110272200
 |
ABBREVIATIONS |
The abbreviations used are:
serpin, serine
protease inhibitor;
1AT,
1-antitrypsin;
PPE, porcine pancreatic elastase;
HLE, human leukocyte elastase;
SI, stoichiometry of inhibition.
 |
REFERENCES |
| 1.
|
Anfinsen, C. B.
(1973)
Science
181,
223-230[Free Full Text]
|
| 2.
|
Huber, R.,
and Carrell, R. W.
(1989)
Biochemistry
28,
8951-8966[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Carr, C. M.,
and Kim, P. S.
(1993)
Cell
73,
823-832[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Chan, D. C.,
Fass, D.,
Berger, J. M.,
and Kim, P. S.
(1997)
Cell
89,
263-273[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Orosz, A.,
Wisniewski, J.,
and Wu, C.
(1996)
Mol. Cell. Biol.
16,
7018-7030[Abstract]
|
| 6.
|
Stein, P. E.,
and Carrell, R. W.
(1995)
Nat. Struct. Biol.
2,
96-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Pemberton, P. A.,
Stein, P. E.,
Pepys, M. B.,
Potter, J. M.,
and Carrell, R. W.
(1988)
Nature
336,
257-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Ma, J.,
Yee, A.,
Brewer, H. B., Jr.,
Das, S.,
and Potter, H.
(1994)
Nature
372,
92-94[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Abraham, C. R.,
Selkoe, D. J.,
and Potter, H.
(1988)
Cell
52,
487-501[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Stefansson, S.,
and Lawrence, D. A.
(1996)
Nature
383,
441-443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Rubin, H.,
Wang, Z.-M.,
Nickbarg, E. B.,
McLarney, S.,
Naidoo, N.,
Schoenberger, O. L.,
Johnson, J. L.,
and Cooperman, B. S.
(1990)
J. Biol. Chem.
265,
1199-1207[Abstract/Free Full Text]
|
| 12.
|
Wright, H. T.,
and Scarsdale, J. N.
(1995)
Proteins Struct. Funct. Genet.
22,
210-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Huntington, J. A.,
Read, R. J.,
and Carrell, R. W.
(2000)
Nature
407,
923-926[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Kwon, K.-S.,
Kim, J.,
Shin, H. S.,
and Yu, M.-H.
(1994)
J. Biol. Chem.
269,
9627-9731[Abstract/Free Full Text]
|
| 15.
|
Lee, K. N.,
Park, S. D.,
and Yu, M.-H.
(1996)
Nat. Struct. Biol.
3,
497-500[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Im, H.,
Seo, E. J.,
and Yu, M.-H.
(1999)
J. Biol. Chem.
274,
11072-11777[Abstract/Free Full Text]
|
| 17.
|
Seo, E. J., Im, H.,
Maeng, J.-S.,
Kim, K. E.,
and Yu, M.-H.
(2000)
J. Biol. Chem.
275,
16904-16909[Abstract/Free Full Text]
|
| 18.
|
Lee, C.,
Park, S.-H.,
Lee, M.-Y.,
and Yu, M.-H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
7727-7731[Abstract/Free Full Text]
|
| 19.
|
Elliott, P. R.,
Abrahams, J.-P.,
and Lomas, D. A.
(1998)
J. Mol. Biol.
275,
419-425[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Kim, S.-J.,
Woo, J.-R.,
Seo, E. J., Yu, M.-H.,
and Ryu, S.-E.
(2001)
J. Mol. Biol.
306,
109-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ryu, S.-E.,
Choi, H.-J.,
Kwon, K.-S.,
Lee, K. N.,
and Yu, M.-H.
(1996)
Structure
4,
1181-1192[Medline]
[Order article via Infotrieve]
|
| 22.
|
Lee, C.,
Maeng, J.-S.,
Kocher, J.-P.,
Lee, B.,
and Yu, M.-H.
(2001)
Protein Sci.
10,
1446-1453[Abstract/Free Full Text]
|
| 23.
|
Im, H.,
and Yu, M.-H.
(2000)
Protein Sci.
9,
934-941[Abstract]
|
| 24.
|
Edelhoch, H.
(1967)
Biochemistry
6,
1948-1954[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Pace, C. N.,
Shirley, B. A.,
and Thomson, J. A.
(1989)
in
Protein Structure: A Practical Approach
(Creighton, T. E., ed)
, pp. 311-330, IRL Press, New York
|
| 26.
|
Hopkins, P. C. R.,
Carrell, R. W.,
and Stone, S. R.
(1993)
Biochemistry
32,
7650-7657[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Rubin, H.,
Plotnick, M.,
Wang, Z.-M.,
Liu, X.,
Zhong, Q.,
Schechter, N. M.,
and Cooperman, B. S.
(1994)
Biochemistry
33,
7627-7633[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Beatty, K.,
Bieth, J.,
and Travis, J.
(1980)
J. Biol. Chem.
255,
3931-3934[Abstract/Free Full Text]
|
| 29.
|
Shore, J. D.,
Day, D. E.,
Francis-Chmura, A. M.,
Verhamme, I.,
Kvassman, J.,
Lawrence, D. A.,
and Ginsburg, D. A.
(1995)
J. Biol. Chem.
270,
5395-5398[Abstract/Free Full Text]
|
| 30.
|
Engh, R. A.,
Huber, R.,
Boed, W.,
and Schulze, A. J.
(1995)
Trends Biotechnol.
13,
503-510[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Wright, H. T.
(1998)
BioEssays
18,
453-464
|
| 32.
|
Silverman, G. A.,
Bird, P. I.,
Carrell, R. W.,
Church, F. C.,
Coughlin, P. B.,
Gettins, P. G.,
Irving, J. I.,
Lomas, D. A. W.,
Luke, C. J.,
Moyer, R. W.,
Pemberton, P. A.,
Remold-O'Donnell, E.,
Salvesen, G. S.,
Travis, J.,
and Whisstock, J. C.
(2001)
J. Biol. Chem.
276,
33293-33296[Free Full Text]
|
| 33.
|
Plotnick, M. I.,
Mayne, L.,
Schechter, N. M.,
and Rubin, H.
(1996)
Biochemistry
35,
7586-7590[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Lawrence, D. A.,
Olson, S. T.,
Muhammad, S.,
Day, D. E.,
Kvassman, J.,
Ginsburg, D. A.,
and Shore, J. D.
(2000)
J. Biol. Chem.
275,
5839-5844[Abstract/Free Full Text]
|
| 35.
|
Kim, D.,
and Yu, M.-H.
(1996)
Biochem. Biophys. Res. Commun.
226,
378-384[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Loebermann, H.,
Tokuoka, R.,
Deisenhofer, J.,
and Huber, R.
(1984)
J. Mol. Biol.
177,
531-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Kraulis, P. J.
(1991)
J. App. Crystallogr.
24,
946-950[CrossRef]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.